Abstract
When factor XII was adsorbed to kaolin it slowly became activated and converted prekallikrein to kallikrein. In the presence of HMW-kininogen the rate of activation of factor XII and consequently that of prekallikrein was markedly enhanced. The enhancing effect of HMW-kininogen was a dose-dependent phenomenon. In order to enhance the activation of factor XII on a surface the HMW-kininogen molecule had to be intact. Cleavage of HMW-kininogen by kallikrein decreased the enhancing effect of HMW-kininogen, there being an inverse relation between the bradykinin-generated and the capacity to enhance factor XII activation. Another ‘potentiator’ of factor XII activation was isolated from proteins adsorbed to aluminum hydroxide. This potentiator further increased the activation of factor XII, also in a dose-dependent fashion. It was postulated that factor XII is slowly converted into its active form by exposure to negatively charged surfaces; that this process is enhanced by kallikrein and further accelerated by HMW-kininogen and the ‘potentiator’; and that these enhancing substances probably act by opening active sites on the factor XII molecule.
Similar content being viewed by others
References
C.G. Cochrane, S.D. Revak, R. Ulevitch, A. Johnston andD. Morrison,Hageman Factor: Characterization and Mechanism of Activation, in:Chemistry and Biology of the Kallikrein-Kinin System in Health and Disease.Fogarty International Center Proc. No. 27 (Eds. J.J. Pisano and K.F. Austen; U.S. Govt. Printing Office, Washington, 1976).
H.Z. Movat andA.H. Özge-Anwar,The Contact Phase of Blood Coagulation: Clotting Factor XI and XII, their Isolation and Interaction, J. Lab. Clin. Med.84 861 (1974).
A.H. Özge-Anwar, H.Z. Movat andJ.G. Scott,The Kinin System of Human Plasma. IV. The Interrelationship Between the Contact Phase of Blood Coagulation and the Plasma Kinin System in Man, Thromb. Diath. Haemorrh.27, 141 (1972).
C.G. Cochrane andK.D. Wuepper,Activation of Hageman Factor in Solid and Fluid Phases. A Critical Role of Kallikrein, J. Exp. Med.138, 1564 (1973).
K.D. Wuepper,Prekallikrein Deficiency in Man, J. Exp. Med.138, 1345 (1973).
A.S. Weiss, J.I. Gallin andA.P. Kaplan,Fletcher Factor Deficiency: Abnormalities of Coagulation, Fribrinolysis, Chemotactic Activity and Kinin-Generation Attributable to Absence of Prekallikrein, J. Clin. Invest.53, 622 (1973).
R. Waldmann andJ.P. Abraham,Fitzgerald Factor: a Heretofor Unrecognized Coagulation Factor, Blood44, 934 (1974).
H. Saito, O.D. Ratnoff, R. Waldmann andJ.P. Abraham,Fitzgerald Factor, Participating in Surface-Mediated Reactions of Clotting, Fibrinolysis, Generation of Kinins and the Property of Diluted Plasma Enhancing Vascular Permeability [Pf/dil), J. Clin. Invest.55, 1082 (1975).
R.W. Colman, A. Bagdasarian, R.C. Talamo, C.F. Scott, M. Seaven, J.A. Guimarães, J.V. Pierce andA.P. Kaplan.Williams Trait: Human Kininogen Deficiency with Diminished Levels of Plasminogen Proactivator and Prekallikrein Associated with Abnormalities of the Hageman Factor-Dependent Pathways, J. Clin. Invest.56, 1650 (1975).
K.D. Wuepper, D.R. Miller andM.J. Lacombe,Fleaujac Trait: Deficiency of Human Plasma Kininogen, J. Clin. Invewt.56, 1663 (1975).
M.E. Webster, J.A. Guimarães, A.P. Kaplan, R.W. Colman andJ.V. Pierce Activation of Surface-Bound Hageman Factor: Preeminent Role of High Molecuar Weight Kininogen and Evidence for a New Factor, in:Kinins, Pharmacodynamics and Biological Roles (Eds. F. Sicuteri, N. Back, and G.L. Haberland; Plenum Press, New York/London, 1976).
V.H. Donaldson, H.I. Glueck, M.A. Miller, H.Z. Movat andF.M. Habal,Kininogen Deficiency in Fitzgerald Trait: Role of High Molecular Weight Kininogen in Clotting and Fibrinolysis, J. Lab. Clin. Med.87, 327 (1976).
S. Schiffman andP. Lee,Preparation, Characterization, and Activation of a Highly Purified Factor XI: Evidence that a Hitherto Unrecognized Plasma Activity Participates in the Interaction of Factors XI and XII. Brit. J. Haematol.27, 101 (1974).
S. Schiffman andP. Lee,Partial Purification of Contact Activation Cofactor, J. Clin. Invest.56, 1082 (1975).
S. Schiffman, P. Lee andR. Waldmann,Identity of Contact Activation Cofactor and Fitzgerald Factor, Thromb. Res.6, 451 (1975).
A.P. Kaplan, H.L. Meier andR. Mandle, Jr.,The Hageman Factor Dependent Pathways of Coagulation, Fibrinolysis and Kinin-Generation, Seminars Thromb.3, (1976).
J.H. Griffin andC.G. Cochrane,Mechanisms for the Involvement of High Molecular Weight Kininogen in Surface-Dependent Reactions of Hageman Factor, Proc. Nat. Acad. Sci. (USA)73, 2554 (1976).
J.Y.C. Chan, C.E. Burrowes, F.M. Habal andH.Z. Movat,Interaction Between Factor XII (Hageman Factor), High Molecular Weight Kininogen and Prekallikrein, Thromb. Res.9, 423 (1976).
J.Y.C. Chan andH.Z. Movat,Purification of Factor XII (Hageman Factor) from Human Plasma, Thromb. Res.8, 337 (1976).
F.M. Habal, H.Z. Movat andC.E. Burrowes,Isolation of Two Functionally Different Kininogens from Human Plasma—Separation from Proteinase Inhibitors and Interaction with Plasma Kallikrein, Biochem. Pharmacol.23, 2291 (1974).
F.M. Habal andH.Z. Movat,Rapid Purification of Human High Molecular Weight Kininogen, Agents and Actions6, 565 (1976).
F.M. Habal, C.E. Burrowes andH.Z. Movat, Generation of Kinin by Plasma Kallikrein and Plasmin and the Effect of α1-Antitrypsin and antithrombin III in the Kininogenases, in:Kinins, Pharmacodynamics and Biological Roles (Eds. F. Sicuteri, N. Black and G.L. Haberland; Plenum Press, New York/London, 1976).
C.E. Burrowes andH.Z. Movat, Isolation of Antithrombin III from Human Plasma: Its Separation from α1-Antitrypsin, Biochem. Biophys. Res. Comm.74, 140 (1977).
J.Y.C. Chan, C.E. Burrowes andH.Z. Movat,The Inhibition of Activated Factor XII (Hageman Factor) by Antithrombin III; the Effect of Other Plasma Proteinase Inhibitors, Biochem. Biophys. Res. Comm.74, 150 (1977).
S.D. Revak, C.G. Cochrane, A.R. Johnston andT.E. Hugli,Structural Changes Accompanying Enzymatic Activation of Human Hageman Factor, J. Clin. Invest.54, 619 (1974).
M.J. Soltay, H.Z. Movat andA.H. Özge-Anwar,The Kinin System of Human Plasma. V. The Probable Derivation of Prekallikrein Activator from Activated Hageman Factor (XIIa), Proc. Soc. Exp. Biol. Med.138, 952 (1971).
A.P. Kaplan andK.F. Austen,A Prealbumin Activator of Prekallikrein. II. Derivation of Activators of Prekallikrein from Active Hageman Factor by Digestion with Plasmin, J. Exptl. Med.133, 696 (1971).
C.E. Burrowes, H.Z. Movat andM.J. Soltay,The Kinin System of Human Plasma. VI. The Action of Plasmin, Proc. Soc. Exp. Biol. Med.138, 959 (1971).
A. Bagdasarian, B. Lahiri andR.W. Colman,Origin of the High Molecular Weight Activator of Prekallikrein, J. Biol. Chem.248, 7742 (1973).
R. Waldmann, A.G. Scicli, R.K. McGregor, O.A. Carretero, J.P. Abraham, H. Kato, Y.N. Han andS. Iwanaga,Effect of Bovine High Molecular Weight Kininogen and its Fragments on Fitzgerald Trait Plasma, Thromb. Res.8, 785 (1976).
R.T. Matheson, D.R. Miller, M-J. Lacombe, Y.N. Han, S. Iwanaga, H. Kato andK.D. Wuepper,Fleaujac Factor Deficiency. Reconstitution with Highly Purified Bovine High Molecular Weight Kininogen and Delineation of a New Permeability-Enhancing Peptide Released by Plasma Kallikrein from Bovine High Molecular Weight Kininogen, J. Clin. Invest.58, 1395 (1976).
H. Kato, Y.N. Han, S. Iwanaga, T. Suzuki andM. Komiya,Bovine HMW and LMW-Kininogens: Isolation and Characterization of the Polypeptide Fragments Produced by Plasma and Tissue Kallikrein, in:Kinins, Pharmacodynamics and Biological Role (Eds. F. Sicuteri, N. Back and G.L. Haberland; Plenum Press, New York/London, 1976).
J.Y.C. Chan, C.E. Burrowes andH.Z. Movat,Activation of Factor XII (Hageman Factor): Enhancing Effect of a Potentiator Thromb. Res. (1977) in press.
C.R. McMillin, H. Saito, O.D. Ratnoff andA.D. Walton,The Secondary Structure of Hageman Factor (Factor XII). J. Clin. Invest.54, 1313 (1974).
Author information
Authors and Affiliations
Additional information
Supported by a grant from the Ontario Heart Foundation.
Supported by the Medical Research Council of Canada.
Rights and permissions
About this article
Cite this article
Chan, J.Y.C., Burrowes, C.E. & Movat, H.Z. Surface activation of factor XII (Hageman factor) — Critical role of high molecular weight kininogen and another potentiator. Agents and Actions 8, 65–72 (1978). https://doi.org/10.1007/BF01972404
Issue Date:
DOI: https://doi.org/10.1007/BF01972404